Cuban center to export products to Southern African markets

HAVANA, Cuba, Dec 11 (ACN) The Center for Placental Histotherapy (Hisplacen) announced today the signing of a contract for the export of products derived from human placenta to the markets of the Southern African Development Community (SADC).

According to a Hisplacen publication on X, the agreement was signed in a multinational alliance with the company Broadening Your Horizons and supported by FarmaCuba, an importer and exporter of Cuban pharmaceutical products and supplies.

The entity explained on Facebook that this proposal comes thanks to the commercialization of a unique product portfolio of its kind (based on selected placental extracts) plus the innovative, academic and business support of an alliance with the capacity to evolve organically.

Multiple dynamic working days that resulted in the construction of its own route to growth and consolidation, the text added.

Hisplacen is a company belonging to the Biotechnology and Pharmaceutical Industries Group, BioCubaFarma, and has more than 25 years of experience in the treatment of dermatological conditions.

Its portfolio of products derived from human placenta includes drugs such as Melagenina Plus, for the treatment of vitiligo, Coriodermina, to treat psoriasis, and the dietary supplement Biopla.

It also develops Dermoplacen, in hair line (lotion, shampoo and conditioner), facial line (creams, soap, make-up, aftershave lotion) and body line (moisturizing gel, dermal bioactivator, photoprotector, cream, pigmenting lotion and nail biofortifier).